AI startup Edison raises $70M seed for research softwarenews2025-12-18T17:51:57+00:00December 18th, 2025|Endpoints News|
AI biotech preview of 2026: Clinic takes center stagenews2025-12-17T14:00:16+00:00December 17th, 2025|Endpoints News|
Verge Genomics’ ALS drug fails as biotech shifts to partner modelnews2025-12-16T20:04:38+00:00December 16th, 2025|Endpoints News|
AI biotech Chai Discovery raises $130M Series B at $1.3B valuationnews2025-12-15T12:30:37+00:00December 15th, 2025|Endpoints News|
Formation Bio signs deal for TYK2 drug from China’s Lynknews2025-12-10T12:00:15+00:00December 10th, 2025|Endpoints News|
Novartis to partner with AI-focused Relation on atopic diseasesnews2025-12-09T16:19:37+00:00December 9th, 2025|Endpoints News|
“Heavy AI” is taking over biopharma | Signal Pulse Reportnews2025-12-01T13:53:30+00:00December 1st, 2025|Endpoints News|
Generate:Biomedicines to start Phase 3 studies for TSLP antibodynews2025-12-01T11:00:16+00:00December 1st, 2025|Endpoints News|
AI biotech Profluent closes $106M raise with Jeff Bezos’ supportnews2025-11-19T15:15:30+00:00November 19th, 2025|Endpoints News|
Nabla Bio announces AI antibody model update in JAM-2news2025-11-19T10:00:53+00:00November 19th, 2025|Endpoints News|
